Finding opportunities in Biotech ER or buy-side to exit medicine

I have a long personal story on how I arrived here, but it's definitely not novel just from browsing the forums here: new doctor looking to leave medicine for finance. 

I am a recently-started surgical preliminary intern (applied to a surgical subspecialty and didn't match) looking to exit medicine. I became very disenchanted with the process and, while I believe I have a strong enough application to reapply or even change specialties, the long-term upside doesn't really seem worth destroying my mental in the process. The love of medicine and patient care just don't outweigh having to endure the training process for me.  To be clear, I am not afraid of working long hours and had very much accepted that I'd be putting in my ACGME-regulated "80 hours" for the next 5 to 6 years; it's just that the long-term goal doesn't seem worth it anymore (culture, industry trends, opportunity cost), especially starting residency at 30. 

I got the idea of looking into biotech equity research and biotech-focused hedge funds from family working in finance as a potential pivot to leverage my educational background (ivy league undergrad, meh med school) and my research resume for recruiting. My understanding of the day-to-day of being an ER associate or analyst is that it's fairly similar to how I spent my research year (which I enjoyed).

Through some personal networking, I've connected and chatted with individuals at a couple biotech-focused hedge funds and got some general ideas.  However, I still feel lost about what competencies I should be honing or developing, how to develop them, and where to look for opportunities to break in. Like trying to develop a stock pitch without any guidance has been difficult even though I've enjoyed learning about some companies and the indications they are targeting.  

If anybody has similar experience, I'd be very grateful to connect for some guidance. Thank you! 

4 Comments
 

Based on the most helpful WSO content, here are some insights and advice for transitioning from medicine to biotech equity research (ER) or the buy-side:

Exit Opportunities in Biotech ER or Buy-Side

  1. Competencies to Develop:

    • Financial Analysis Skills: Understanding financial statements, valuation techniques, and financial modeling is crucial. Consider taking courses or certifications in these areas.
    • Industry Knowledge: Deepen your understanding of the biotech and pharmaceutical industries, including drug development processes, regulatory environments, and market dynamics.
    • Stock Pitch Development: Practice creating and presenting stock pitches. This involves analyzing a company's financial health, market position, and growth potential.
  2. Educational Background:

    • Your Ivy League undergraduate education and medical school background are strong assets. Highlight these in your applications and networking efforts.
    • Consider pursuing an MBA or relevant certifications (e.g., CFA) to bolster your finance credentials.
  3. Networking:

    • Continue leveraging personal connections in finance. Networking is key in breaking into ER or buy-side roles.
    • Attend industry conferences, webinars, and networking events to meet professionals in biotech finance.
  4. Practical Experience:

    • Seek internships or part-time roles in biotech ER or at biotech-focused hedge funds to gain hands-on experience.
    • Engage in independent research projects or contribute to finance-related publications to build your resume.
  5. Resources and Guidance:

    • Utilize forums like Wall Street Oasis to connect with individuals who have made similar transitions. They can provide valuable insights and mentorship.
    • Look for guides and resources on evaluating biotech companies, as these can provide frameworks and methodologies for your analyses.

Additional Insights from WSO Threads:

  • Doctor Thinking of Exit Opportunities: Physicians have successfully transitioned to equity research or management consulting in biotech/pharma/healthcare. The analytical and critical thinking skills developed in medicine are highly valued in these roles.
  • 2nd Year Biotech Equity Research Looking for Next Steps: Transitioning from ER to healthcare banking or buy-side roles is feasible, especially with a strong science background. Networking and gaining relevant experience are crucial steps.

By focusing on these areas, you can effectively pivot from medicine to a career in biotech equity research or the buy-side. Good luck!

Sources: Doctor thinking of exit opportunities, 2nd yr Biotech Equity Research looking for next steps......, Biotech equity research possible with ZERO finance experience?, Feel Trapped, Exit Opps From Sell-Side ER?, Where does ER go from here?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Assumenda voluptatibus molestias reiciendis amet unde fugit. Numquam vel perspiciatis architecto beatae. Sint eius id laborum qui rerum. Harum ut velit quisquam aliquid iste vitae laudantium molestiae.

Quia aspernatur non optio. Consectetur impedit facere repudiandae eveniet sed quia. Vitae quae nihil doloremque. Tempore nihil sed dolorum et. Minus maxime animi mollitia deserunt excepturi. Dolorem dolores ipsam vitae.

Est quasi cumque qui assumenda consequuntur. Iure consectetur nesciunt quidem officia quia culpa. Harum odio natus provident fuga sapiente ea quae. Quasi autem minus minus. Sapiente minima autem quos libero laboriosam nesciunt qui aliquid. Ut minima autem minus nostrum dolor ea. Voluptatem aut nihil doloremque et consequatur et.

Ratione nulla repellat est voluptatem. Id autem odio qui et ex. Adipisci quis ipsam quis dolorem sit.

 

Optio amet ratione velit facilis deleniti. Reprehenderit suscipit laborum accusamus enim. Aspernatur facere repudiandae non labore quasi aliquam sit qui. Consequuntur reiciendis temporibus consequatur voluptatem velit ad excepturi.

Dolor laborum quos minima placeat commodi voluptatem. Est ea velit at tempora. Ratione et aut dolore accusantium excepturi.

Aliquam sapiente quos eius autem illo consequatur. Occaecati nisi impedit velit nemo. Aut velit rerum perspiciatis sit dolorem omnis. Sequi possimus aut deserunt impedit voluptatibus unde consectetur quia.

Fuga voluptatem eaque fugiat ipsa iusto. Voluptas non veniam illum. Doloremque qui aspernatur dolorem ad aut magni doloribus. Totam et cum nisi inventore enim pariatur. Maxime repellat laboriosam sed soluta.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
DrApeman's picture
DrApeman
98.9
7
GameTheory's picture
GameTheory
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”